Delivery Order SPE2DB20D1004-SPE2DB25FNJAF
- Not listed
- The Defense Logistics Agency awarded a $52,402.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 1 mg/dose in 3 mL vials, with a completion date of September 15, 2025. This is a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $32,686.40 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 1 mg/dose in 3 mL vials on September 19, 2025, with completion scheduled for September 22, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,837.41 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price contract with no set-aside designation, issued on July 10, 2025, with an ultimate completion date of July 11, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This award represents a single delivery order under...
- The Defense Logistics Agency (DLA) awarded a $3,297.43 delivery order contract to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Ozempic (semaglutide) 1 mg/dose in 4 mg/3 mL vials. The contract is a firm fixed price delivery order with an ultimate completion date of May 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation and represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,793.77 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 1 mg/dose in 3 ml vials. This firm fixed-price delivery order, issued on October 24, 2025, with completion expected by October 27, 2025, represents a non-competitive contract award. The product will be supplied to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,018.51 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of June 3, 2025. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery...
- The Defense Logistics Agency awarded a $22,373.10 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 2 mg/dose in 3 mL vials. This competitive award, issued on September 17, 2025, with a completion date of September 18, 2025, reflects a firm fixed-price delivery order under a larger contract vehicle. The order is being fulfilled from the vendor's Corporate Office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters. As a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,855.50 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml configurations. This firm fixed-price, competitively awarded contract was executed on August 6, 2025, with an ultimate completion date of August 7, 2025, and represents a pharmaceutical delivery to support federal medical procurement needs. The work is being performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a ceiling value of $18,294.14. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,324.69 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3 mL formulations. The award was issued on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNJAFDelivery Order
The Defense Logistics Agency (DLA) awarded a $2,506.64 delivery order to AmerisourceBergen Drug Corp for Ozempic (semaglutide) 1 mg/dose in 3 mL vials on June 27, 2025, with completion targeted for June 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical support vehicle running through December 2026 that supplies a broad range of medications and medical supplies to support military healthcare operations worldwide. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor within the federal medical supply chain, fulfilling a substantial volume of DLA procurement requirements across multiple therapeutic categories including specialty medications, vaccines, and medical devices. As the prime contractor on this delivery order, the company leverages its established IDC to provide pharmaceutical products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award demonstrates AmerisourceBergen's ongoing role as a key vendor in supporting military medical readiness and healthcare requirements across global operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 6/27/25 |